Back to results
US 7,582,608 B2Granted
Selective VPAC2 receptor peptide agonists
AssigneeEli Lilly and Company
InventorsBengt Krister Bokvist, Lianshan Zhang, Jorge Alsina-Fernandez
Life of this patent
Estimating the term…
Abstract
The present invention encompasses peptides that selectively activate the VPAC2 receptor and are useful in the treatment of diabetes.
Claims3
A PEGylated VPAC2 receptor peptide agonist consisting of:
- C6-HSDAVFTEQY(OMe)TOrnLRAibQLAAbuAibOrnYAibQAibIOrnOrnGGPSSGAPPPC(PE G20K)C(PEG20K)-NH2 (SEQ ID NO:
- 66).
Dependencies are inferred from the claim text.